MMP9 Variation After Thrombolysis Is Associated With Hemorrhagic Transformation of Lesion and Death

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Stroke

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.113.002274PMID 23908067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice.

  2012cited by this paper
• Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.

  2011cited by this paper
• Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.

  2010cited by this paper
• Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion.

  2008cited by this paper
• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study

  2008cited by this paper
• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

  2007cited by this paper
• Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Secondary Analysis of the European-Australasian Acute Stroke Study (ECASS II)

  2001cited by this paper
• Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia

  1999cited by this paper
• Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.

  1998cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1996cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper

• Combined treatment with tPA and Chinese herbal medicine for ischemic stroke: is it valuable?

  2026cites this paper
• Urban PM2.5 Impairs Blood–Brain Barrier Integrity and Enhances LOX-1 Expression in Human Brain Endothelial Cells

  2026cites this paper
• Feasibility of recent peptide therapy for ischemic stroke: a comprehensive exploration.

  2025cites this paper
• Systemic inflammation response index as a predictor of 3-month functional outcomes in acute ischemic stroke patients following intravenous thrombolysis.

  2025cites this paper
• Association between lower neutrophil-to-albumin ratio and early neurological improvement in patients with acute cerebral infarction after intravenous thrombolysis.

  2024cites this paper
• Jingfang granules protects against intracerebral hemorrhage by inhibiting neuroinflammation and protecting blood-brain barrier damage

  2024cites this paper
• Assessing the predictive value of neutrophil percentage to albumin ratio for ICU admission in ischemic stroke patients

  2024cites this paper
• Advancing stroke therapy: A deep dive into early phase of ischemic stroke and recanalization

  2024cites this paper
• The role of neutrophils in tPA thrombolysis after stroke: a malicious troublemaker

  2024cites this paper
• Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: go broad or go narrow?

  2024cites this paper
• Histidine-rich glycoprotein modulates neutrophils and thrombolysis-associated hemorrhagic transformation

  2024cites this paper
• Combined Therapeutics: Future Opportunities for Co-therapy with Thrombectomy

  2023cites this paper
• The Role of Extracellular Matrix and Inflammation in the Stratification of Bleeding and Thrombotic Risk of Atrial Fibrillation on Oral Anticoagulant Therapy: Insights from Strat-Af Study

  2023cites this paper
• LOX-1 and MMP-9 inhibition attenuates the detrimental effects of delayed rt-PA therapy and improves outcomes after acute ischemic stroke

  2023cites this paper
• SGLT2 inhibitor dapagliflozin alleviates intramyocardial hemorrhage and adverse ventricular remodeling via suppressing hepcidin in myocardial ischemia-reperfusion injury.

  2023cites this paper
• Polymorphisms of the Matrix Metalloproteinase Genes are Associated with Acute Ischemic Stroke in Chinese Han Population

  2023cites this paper
• Small Vessel Disease: Ancient Description, Novel Biomarkers

  2022cites this paper
• Stroke Biomarkers: Issues of Diagnosis and Medical Rehabilitation

  2022cites this paper
• Nuclear Magnetic Resonance-Based Metabolomics to Predict Early and Late Adverse Outcomes in Ischemic Stroke Treated with Intravenous Thrombolysis

  2022cites this paper
• Leukocyte indicators and variations predict worse outcomes after intravenous thrombolysis in patients with acute ischemic stroke

  2022cites this paper
• Recent advances in drug delivery and targeting to the brain.

  2022cites this paper
• Risk Factors and Mechanism of Hemorrhagic Transformation of Acute Ischemic Cerebral Infarction

  2022cites this paper
• Implications of age-related changes in the blood-brain barrier for ischemic stroke and new treatment strategies

  2022cites this paper
• Fluid biomarkers in stroke: From animal models to clinical care

  2022cites this paper
• Machine Learning-Based Model for Prediction of Hemorrhage Transformation in Acute Ischemic Stroke After Alteplase

  2022cites this paper
• Prognostic value of serum MMP-9 level in acute ischemic stroke patient

  2022cites this paper
• Predictive values of baseline matrix metalloproteinase 9 levels in peripheral blood on 3‐month outcomes of high‐risk patients with minor stroke or transient ischemic attack

  2022cites this paper
• Cerebral edema in acute stroke: Effect of thrombolytic treatment.

  2022cites this paper
• Analysis of Metabolite and Lipid Association Networks Reveals Molecular Mechanisms Associated with 3-Month Mortality and Poor Functional Outcomes in Patients with Acute Ischemic Stroke after Thrombolytic Treatment with Recombinant Tissue Plasminogen Activator

  2021cites this paper
• Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke

  2021cites this paper
• Prognostic value of the neutrophil-to-lymphocyte ratio in acute ischemic stroke patients treated with intravenous thrombolysis: a systematic review and meta-analysis

  2021cites this paper
• Prognostic Value of Neutrophil To Lymphocyte Ratio In Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis: A Meta-Analysis

  2021cites this paper
• Down-regulation of circular RNA CDC14A peripherally ameliorates brain injury in acute phase of ischemic stroke

  2021cites this paper
• TT genotype of the MMP‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke

  2021cites this paper
• PPARγ activation suppresses the expression of MMP9 by downregulating NF-κB post intracerebral hemorrhage.

  2021cites this paper
• Analysis of the association of MPO and MMP-9 with stroke severity and outcome

  2020cites this paper
• YiQiFuMai Lyophilized Injection ameliorates tPA-Induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways.

  2020cites this paper
• Safety and outcome of decompressive hemicraniectomy after recombinant tissue plasminogen activator (rtPA) thrombolysis for acute ischemic stroke: A systematic review.

  2020cites this paper
• Toll-Like Receptor 4 Signaling in Focal Cerebral Ischemia: a Focus on the Neurovascular Unit

  2020cites this paper
• Association of Matrix Metalloproteinase 9 and Cellular Fibronectin and Outcome in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

  2020cites this paper
• Matrix Metalloproteinase-9 Relationship With Infarct Growth and Hemorrhagic Transformation in the Era of Thrombectomy

  2020cites this paper
• Development of Brain Targeting Peptide Based MMP-9 Inhibiting Nanoparticles for the Treatment of Brain Diseases with Elevated MMP-9 Activity.

  2020cites this paper
• Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke

  2020cites this paper
• Combined utility of blood glucose and white blood cell in predicting outcome after acute ischemic stroke: The ENCHANTED trial.

  2020cites this paper
• Blood Biomarkers of Parenchymal Damage in Ischemic Stroke Patients Treated With Revascularization Therapies

  2019cites this paper
• Neutrophils in tPA‐induced hemorrhagic transformations: Main culprit, accomplice or innocent bystander?

  2019cites this paper
• Targeting Platelet GPVI Plus rt-PA Administration but Not α2β1-Mediated Collagen Binding Protects against Ischemic Brain Damage in Mice

  2019cites this paper
• Renin-angiotensin system activation and imbalance of matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 in cold-induced stroke.

  2019cites this paper
• High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients

  2019cites this paper
• Effect of Endovascular Therapy on Subsequent Decompressive Hemicraniectomy in Cardioembolic Ischemic Stroke with Proximal Intracranial Occlusion in the Anterior Circulation: Sub-Analysis of the RESCUE-Japan Registry 2

  2019cites this paper
• Influence of Thrombolysis on the Safety and Efficacy of Blocking Platelet Adhesion or Secretory Activity in Acute Ischemic Stroke in Mice

  2018cites this paper
• Small Vessel Disease Is Associated with Tissue Inhibitor of Matrix Metalloproteinase-4 After Ischaemic Stroke

  2018cites this paper
• Influence of Thrombolysis on the Safety and Efficacy of Blocking Platelet Adhesion or Secretory Activity in Acute Ischemic Stroke in Mice

  2018cites this paper
• MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes

  2018cites this paper
• Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice

  2018cites this paper
• Differential leukocyte counts on admission predict outcomes in patients with acute ischaemic stroke treated with intravenous thrombolysis

  2018cites this paper
• Association between matrix metalloproteinase family gene polymorphisms and risk of ischemic stroke: A systematic review and meta-analysis of 29 studies.

  2018cites this paper
• Reperfusion Injury after ischemic Stroke Study (RISKS): single-centre (Florence, Italy), prospective observational protocol study

  2018cites this paper
• Author Response.

  2018cites this paper
• The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

  2018cites this paper
• Predictive value of plasma matrix metalloproteinase-9 concentrations for spontaneous haemorrhagic transformation in patients with acute ischaemic stroke: A cohort study in Chinese patients.

  2018cites this paper
• Elevated MMP-1 and TIMP-1 are related with acute cerebral infarction patients with diabetes mellitus

  2017cites this paper
• Infections and Chlamydia pneumoniae antibodies influence the functional outcome in thrombolysed strokes.

  2017cites this paper
• A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9.

  2017cites this paper
• Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis

  2017cites this paper
• Neuroprotective effects of adjunctive treatments for acute stroke thrombolysis: a review of clinical evidence

  2017cites this paper
• Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes

  2016cites this paper
• Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke

  2016influential citation
• Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke

  2016cites this paper
• The prognostic value of biomarkers in stroke

  2016cites this paper
• Status epilepticus of inflammatory etiology: A cohort study

  2016cites this paper
• Blood biomarkers in the early stage of cerebral ischemia.

  2016cites this paper
• Intraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities.

  2016cites this paper
• Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke

  2016cites this paper
• Mismatch of Low Perfusion and High Permeability Predicts Hemorrhagic Transformation Region in Acute Ischemic Stroke Patients Treated with Intra-arterial Thrombolysis

  2016cites this paper
• Alterations of the Blood-Brain Barrier in Post-Traumatic Epilepsy

  2015cites this paper
• Matrix Metalloproteinase Regulation in Intracerebral Hemorrhage

  2015cites this paper
• Thrombolysis-Related Hemorrhage: Can We Make Thrombolysis Safer?

  2015cites this paper
• Matrix metalloproteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial.

  2015cites this paper
• Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways.

  2015cites this paper
• Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes

  2015cites this paper
• Intramyocardial haemorrhage after acute myocardial infarction

  2015cites this paper
• Relationship of plasma matrix metalloproteinase-9 and hematoma expansion in acute hypertensive cerebral hemorrhage

  2015cites this paper
• Unbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC Study

  2015cites this paper
• Genetic variations of MMP9 gene and intracerebral hemorrhage susceptibility: a case-control study in Chinese Han population.

  2014cites this paper
• Fluid-Attenuated Inversion Recovery Hyperintensity Correlates With Matrix Metalloproteinase-9 Level and Hemorrhagic Transformation in Acute Ischemic Stroke

  2014cites this paper
• Predicted value of circulating matrix metalloproteinase-9 in arteria hypertension patients after acute ischemic stroke

  2014cites this paper
• Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers

  2014cites this paper
• Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.

  2014cites this paper
• Genetic variations of MMP9 gene and intracerebral hemorrhage outcome: a cohort study in Chinese Han population.

  2014cites this paper
• Statins in neurological disorders: an overview and update.

  2014cites this paper
• Hemorrhagic transformation after cerebral infarction: current concepts and challenges.

  2014cites this paper
• Early decompressive surgery after combined intra-venous thrombolysis and endovascular stroke treatment.

  2014cites this paper
• MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke

  2013cites this paper
• International Journal of Molecular Sciences the Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke

  year unknowncites this paper
• Геморрагическая трансформация инфаркта мозга: классификация, патогенез, предикторы и влияние на функциональный исход

  year unknowncites this paper